Higher Community Wellbeing Linked to Reduced CVD Mortality in Study of More than 3000 US Counties
Wellbeing is considered a measurable and modifiable community attribute that study authors show is correlated with CV outcomes.
Frequent Opioid Use for Low Back Pain, Neck Pain Called into Question in New Study
Results showed that the use of opioid analgesics did not confer any benefits for adults with acute low back pain or neck pain compared to placebo.
Daily Dose: Childhood Glycemic Measures as Predictors of Diabetes-Related Complications
Your daily dose of clinical news you may have missed.
Treating Obesity & T2D: Experts Say Simultaneous, Early Intervention is Key
Early intervention is crucial to help prevent complications in patients with obesity and type 2 diabetes. Two experts explain more, here.
Telehealth Certification Program Offered by the American Heart Association
The certification is available to all health care professionals and aims to standardize training and increase skills in telehealth care delivery and integration into practice.
US Maternal Mortality Doubled 1999-2019, Remains Highest Among Black Women
The greatest increase over the 10 years was seen in deaths among American Indian and Alaska Native women, according to Institute for Health Metrics and Evaluation data.
Monthly Vitamin D Supplementation May Lower the Risk of Major CV Events in Older Adults
Vitamin D supplementation may reduce the incidence of major cardiovascular events in older adults, suggests new research.
Daily Dose: Pegozafermin in Patients with NASH
Loneliness Linked to Greater Risk for CVD in Individuals with Diabetes
The predictive value of loneliness for cardiovascular disease in patients with diabetes was stronger than traditional lifestyle risk factors in large UK Biobank analysis.
ADA Updates Standards of Care, Adding Teplizumab for Delay of T1D, Emphasizing Hepatic Disease Management
The ADA's annual update includes refined criteria for type 1 diabetes screening and detailed guidance on detection and management of NAFLD and NASH.
FDA's First Draft Guidance on Clinical Trials with Psychedelic Drugs Now Available for Comment
The FDA's recommendations serve to inform potential research sponsors on development protocols for psychedelics and to solicit comment from industry.
Pegozafermin Shows Early Promise in NASH: Phase 2b ENLIVEN Trial Findings
Pegozafermin, an investigational long-acting (FGF21) analogue, was associated with fibrosis improvement and NASH resolution in an average of 25% of study participants.
Obesity & Type 2 Diabetes: An Expert Discussion
In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.
Daily Dose: High-Dose Oral Semaglutide May be Beneficial for T2D Management
FDA Awards De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Decline in Kidney Function in Adults with Type 2 Diabetes and Early-Stage Kidney Disease
KidneyIntelX.dkd, a first-in-class AI-enabled prognostic test, stratifies risk of DKD progression in 5 years and is specific for early stage disease.
US Overdose Deaths Disproportionately Affect Minority Communities
Black men experienced the highest rate of deaths related to cocaine while American Indian/Native Alaska communities were hit hardest by methamphetamine deaths.
Glycemic Screening in Childhood May Predict Diabetes-Related Complications, According to New Data
ADA 2023: Findings from a new study show that higher levels of glycemia in childhood are associated with future microvascular complications, such as nephropathy and retinopathy.
E-Cigarettes: US Sales Nearly Double over 2 Years, Youth Prefer Flavored Disposables
Sales of e-cigarettes in the US jumped by 46% from 2020-2022; rapid market shifts beg coordinated restrictions to protect public health, says the CDC.
Daily Dose: HF, CV Benefit of SGLT-2 Inhibition Consistent in T2D, CDK, HF
CDC Endorses GSK, Pfizer RSV Vaccines for Older Adults
The 2 new vaccines are authorized for adults aged 60 years and older and with CDC Director Walensky's final nod, should be available this fall.
